The processing of Amyloid Precursor Proteins (APPs) results in several fragments, including soluble N-terminal ectodomains (sAPPs) and C-terminal intracellular domains (AICD). sAPPs have been ascribed neurotrophic or neuroprotective functions in cell culture, although β-cleaved sAPPs can have deleterious effects and trigger neuronal cell death. Here we describe a neuroproprotective function of APP and fly APPL (Amyloid Precursor Protein-like) in vivo in several Drosophila mutants with progressive neurodegeneration. We show that expression of the N-terminal ectodomain is sufficient to suppress the progressive degeneration in these mutants and that the secretion of the ectodomain is required for this function. In addition, a protective effect is achieved by expressing kuzbanian (which has α-secretase activity) whereas expression of fly and human BACE aggravates the phenotypes, suggesting that the protective function is specifically mediated by the α-cleaved ectodomain. Furthermore, genetic and molecular studies suggest that the N-terminal fragments interact with full-length APPL activating a downstream signaling pathway via the AICD. Because we show protective effects in mutants that affect different genes (AMP-activated protein kinase, MAP1b, rasGAP), we propose that the protective effect is not due to a genetic interaction between APPL and these genes but a more general aspect of APP proteins. The result that APP proteins and specifically their soluble α-cleaved ectodomains can protect against progressive neurodegeneration in vivo provides support for the hypothesis that a disruption of the physiological function of APP could play a role in the pathogenesis of Alzheimer's Disease.
Introduction
APP proteins are type-one, membrane-spanning proteins which are subject to proteolytic processing resulting in several distinct fragments (De Strooper and Annaert, 2000; Turner et al., 2003) . Cleavage of human APP 695, the predominant isoform in the brain (Tanaka et al., 1989) , by the β-and γ-secretase generates the Aβ peptides which accumulate in the plaques characteristic for Alzheimer's Disease (Selkoe, 2000) . However, the processing also produces large extracellular fragments, sAPPα after α-processing and sAPPβ after β-processing, in addition to cytoplasmic fragments called AICDs. Both, the sAPP fragments and the AICD contain a number of interaction motifs (De Strooper and Annaert, 2000; Turner et al., 2003) which are shared by APPL (Amyloid Precursor Protein-like), the Drosophila orthologue of APP. APPL is approximately 30% identical to human APP 695 , with significantly higher homology in specific extracellular domains and in the AICD (Martin-Morris and White, 1990). We recently showed that APPL can be processed by secretases resembling the α-, β-, and γ-secretases (Carmine-Simmen et al., 2009), resulting in proteolytic fragments that are comparable to APP fragments. Also similar to APP 695 , APPL is expressed in all neurons and during embryogenesis it is especially abundant in growing axons and in areas of synapse formation (Luo et al., 1990) . Most strikingly, flies lacking APPL exhibit behavioral phenotypes that can be partially rescued by expression of human APP 695 (Luo et al., 1992) .
Although this structural and functional conservation from fly to human suggests an important function, relatively little is known about the physiological roles of APP proteins and their fragments. While the AICD of APP 695 has been connected with transcriptional regulation (Kimberly et al., 2001) , the soluble fragments have been shown to interact with the extracellular matrix (Beher et al., 1996) and they can promote substrate binding and cell adhesion (Turner et al., 2003) . They have also been shown to have proliferative, neurotrophic, or synaptotrophic effects in cell culture, whereby the potency of sAPPα might be different from that of sAPPβ (Araki et al., 1991; Mucke et al., 1994; Mattson, 1997) . In some studies, only sAPPα 
